The Involvement of PBRM1 in Alveolar Macrophage Development, Homeostasis, and Immune Function
PBRM1 参与肺泡巨噬细胞发育、稳态和免疫功能
基本信息
- 批准号:10605100
- 负责人:
- 金额:$ 4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-01 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAddressAdoptive TransferAffectAlveolarAlveolar MacrophagesAnti-Inflammatory AgentsApoptoticAsthmaBindingBiological AssayBlood-Air BarrierBone MarrowCause of DeathCellsCessation of lifeChimera organismChromatinChromatin Remodeling FactorChronicChronic Obstructive Pulmonary DiseaseCommunicationComplexCuesDNADNA MethylationDataDevelopmentDiseaseElderlyEnvironmentEpigenetic ProcessEpitheliumExhibitsFamilyFunctional disorderFutureGene ExpressionGene Expression ProfileGenerationsGeneticGenetic TranscriptionGoalsGranulocyte-Macrophage Colony-Stimulating FactorHealthHematopoieticHomeostasisHost DefenseHumanImmuneImmune ToleranceImmune responseImmune systemImmunityImmunocompromised HostIndividualInflammatoryInflammatory ResponseInfluenzaKnock-outLongitudinal StudiesLungLung diseasesLung infectionsMacrophageMaintenanceMalignant NeoplasmsMalignant neoplasm of lungMeasuresMicrobeMissionModelingModificationMolecularMononuclearMorbidity - disease rateMusMyelogenousPPAR gammaPathway interactionsPhagocytesPhagocytosisPhenotypePhysiologicalPlayPneumoniaPopulationProcessPropertyPulmonary alveolar structureResearchResearch ProposalsRespiratory Tract InfectionsRoleSentinelSignal TransductionSignaling MoleculeStimulusStressStructure of parenchyma of lungT-Cell ActivationT-LymphocyteTissuesToxinTransforming Growth Factor betaUnited States National Institutes of HealthVariantViralVirus Diseasesadaptive immunitychromatin remodelingcofactorcytokineepigenetic therapyfetalimmune functionimprovedin vivoinfluenza infectionintercellular communicationmonocytemortalitymouse modelnovelpathogenpreventprogramspulmonary functionrecruitresponseself-renewalsurfactanttargeted treatmenttissue repairtranscription factortranscriptome sequencing
项目摘要
PROJECT SUMMARY
Pulmonary disorders like respiratory infections are one of the leading causes of death in the world and result in
millions of deaths annually. The immune system’s initial line of defense against lung disease are mononuclear
phagocytes called alveolar macrophages (AMs). These immune sentinels play an important role during
homeostasis by clearing foreign pathogens like microbes and toxins in the airways of the lungs via
phagocytosis. Additionally, AMs have an active role in pulmonary tissue repair by conducting efferocytosis, a
type of phagocytosis that specifically removes apoptotic cells. By preventing the release of proinflammatory
cytokines while secreting anti-inflammatory signals during efferocytosis, AMs contribute to barrier immunity and
exhibit an immunosuppressive phenotype. Studies have also demonstrated that AMs communicate
intercellularly with epithelial and T cells to prevent unneeded proinflammatory responses. Research into AM
development has shown that tissue-specific cytokines derived from the lungs, such as GM-CSF and TGF-β,
are required for the differentiation of monocytes into mature AMs. This plastic response to the pulmonary
microenvironment is regulated by epigenetic modifications, such as DNA methylation and transcription factor
recruitment. Notably, aberrant AM development and function have been implicated in the progression of
multiple lung malignancies, such as influenza infections, chronic obstructive pulmonary disease, and some
types of lung cancer. Furthermore, dysfunctional AMs can contribute to the increased morbidity and mortality of
elderly and immuno-compromised individuals. As such, this study’s long-term goal to enhance the
understanding of epigenetic mechanisms governing AM development and function tightly aligns with NIH’s
mission to prevent disease and improve human health. The key focus of this project aims to investigate the
role of PBRM1, the defining subunit of the SWI/SNF family PBAF complex, in dictating the development and
function of murine AMs. To elucidate the effects of PBRM1-deletion on AM development and phenotype, I plan
to 1) determine the requirement for PBRM1 in AM development and self-renewal, 2) determine the role of
PBRM1 in transcriptional and epigenetic programs of AMs by performing RNA-seq and ATAC-seq on PBRM1
WT and KO AMs to identify pathways and transcription factors which may be dependent on PBRM1, as well as
overlapping this data with CUT&RUN data of PBRM1 and transcription factors known to drive AM
development, such as PPARγ and PU.1.; and 3) determine the functional effects of myeloid-specific PBRM1
deletion during influenza infection. These studies will assess the epigenetic and transcriptional effects of
PBRM1-loss in AMs and provide evidence for novel co-regulators of PBRM1. In the future, this research will
serve to inform the development of targeted therapies of PBRM1-dependent processes affecting lung disease.
项目总结
肺部疾病,如呼吸道感染,是世界上主要的死亡原因之一,并导致
每年有数百万人死亡。免疫系统对肺部疾病的最初防线是单核细胞
吞噬细胞称为肺泡巨噬细胞(AM)。这些免疫哨兵在体内发挥着重要的作用。
通过清除肺部呼吸道中的外来病原体,如微生物和毒素,实现体内平衡
吞噬作用。此外,肺泡巨噬细胞通过传导胞吐作用在肺组织修复中发挥积极作用。
吞噬细胞的一种类型,能特异性地去除凋亡的细胞。通过阻止促炎因子的释放
细胞因子在胞吐过程中分泌抗炎信号的同时,AM有助于屏障免疫和
表现出免疫抑制表型。研究还表明,AM可以与
与上皮细胞和T细胞之间的细胞间隙,以防止不必要的促炎反应。关于AM的研究
研究表明,来自肺的组织特异性细胞因子,如GM-CSF和转化生长因子-β,
是单核细胞分化为成熟AM所必需的。这种对肺脏的可塑性反应
微环境受表观遗传修饰的调节,如DNA甲基化和转录因子
招聘。值得注意的是,AM发育和功能异常与糖尿病的进展有关
多发性肺部恶性肿瘤,如流感感染、慢性阻塞性肺疾病和一些
肺癌的类型。此外,肺泡巨噬细胞功能障碍会增加其发病率和死亡率。
老年人和免疫功能受损的人。因此,这项研究的长期目标是加强
对AM发育和功能的表观遗传机制的理解与NIH密切相关
使命是预防疾病,改善人类健康。该项目的主要重点是调查
PBRM1是SWI/SNF家族PBAF复合体的定义亚基,在决定发育和
小鼠肺泡巨噬细胞功能。为了阐明PBRM1缺失对AM发育和表型的影响,我计划
1)确定在AM开发和自我更新中对PBRM1的需求;2)确定
PBRM1通过在PBRM1上执行RNA-seq和ATAC-seq在AM转录和表观遗传程序中的作用
WT和KO AM以确定可能依赖于PBRM1的途径和转录因子,以及
将这些数据与PBRM1和已知驱动AM的转录因子的切割和运行数据重叠
发展,如PPARγ和PU.1;和3)决定髓系特异性PBRM1的功能效应
在流感感染期间删除。这些研究将评估表观遗传和转录的影响
PBRM1-AM中的损失,并为PBRM1的新型协同调节提供证据。在未来,这项研究将
用于为影响肺部疾病的PBRM1依赖过程的靶向治疗的发展提供信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HANNAH Caroline RATTU MANDIAS其他文献
HANNAH Caroline RATTU MANDIAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 4万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 4万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 4万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 4万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 4万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 4万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 4万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 4万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 4万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 4万 - 项目类别:
Research Grant














{{item.name}}会员




